Streetbeat News

Analyst Ratings

S

The article provides an in-depth analysis of SentinelOne (NYSE:S) based on 20 recent analyst reviews. The overall sentiment is mixed, with a combination of bullish and bearish perspectives. The average 12-month price target has decreased by 14.67% to $24.43. Key financial metrics such as revenue growth, net margin, ROE, and ROA are discussed, highlighting both strengths and challenges for the company.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 2:00 pm

IIIV

Stephens & Co. analyst Charles Nabhan has reiterated an Overweight rating on i3 Verticals (NASDAQ:IIIV) and maintained a $29 price target.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:59 pm

HRB

Barrington Research has maintained an Outperform rating on H&R Block (NYSE:HRB) and raised the price target from $60 to $70.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:58 pm

VNRX

Benchmark analyst Bruce Jackson has reiterated a Hold rating on VolitionRX (AMEX:VNRX).

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:50 pm

BFRI

Benchmark analyst Bruce Jackson has reiterated a Buy rating on Biofrontera (NASDAQ:BFRI) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:49 pm

MSGS

Macquarie analyst Paul Golding maintains an Outperform rating on Madison Square Garden (NYSE:MSGS) but lowers the price target from $240 to $235.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:48 pm

MSFT

Deep-pocketed investors are showing significant interest in Microsoft (NASDAQ:MSFT) options, with a notable increase in both call and put activities. The options activity suggests a potential price range of $400 to $505 for MSFT. Analysts have mixed ratings, with target prices ranging from $485 to $550.

Portfolio Pulse from Benzinga Insights

August 16, 2024 | 1:47 pm

EBS

Benchmark analyst Robert Wasserman has reiterated a Buy rating on Emergent BioSolutions (NYSE:EBS) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:44 pm

SPHR

Macquarie analyst Paul Golding maintains a Neutral rating on Sphere Entertainment (NYSE:SPHR) and raises the price target from $38 to $47.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:42 pm

CLBT

Lake Street analyst Frank Takkinen maintains a Buy rating on Cellebrite DI (NASDAQ:CLBT) and raises the price target from $13.5 to $17.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 1:39 pm